---
title: "Vortioxetine - Major Depressive Disorder"
sidebar: mydoc_sidebar
permalink: db09068-mesh-d003865-1.html
toc: false 
---


Path ID: `DB09068_MESH_D003865_1`
{% include image.html url="images/db09068-mesh-d003865-1.png" file="db09068-mesh-d003865-1.png" alt="db09068-mesh-d003865-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C557874">MESH:C557874 </a> | vortioxetine | Drug |
| <a href="https://identifiers.org/UniProt:P31645">UniProt:P31645 </a> | Sodium-dependent serotonin transporter | Protein |
| <a href="https://identifiers.org/GO:0051610">GO:0051610 </a> | Serotonin uptake | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D012701">MESH:D012701 </a> | Serotonin | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0060096">GO:0060096 </a> | Serotonin secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/UniProt:P08908">UniProt:P08908 </a> | 5-hydroxytryptamine receptor 1A | Protein |
| <a href="https://identifiers.org/UniProt:P46098">UniProt:P46098 </a> | 5-hydroxytryptamine receptor 3A | Protein |
| <a href="https://identifiers.org/UniProt:P34969">UniProt:P34969 </a> | 5-hydroxytryptamine receptor 7 | Protein |
| <a href="https://identifiers.org/UniProt:P28222">UniProt:P28222 </a> | 5-hydroxytryptamine receptor 1B | Protein |
| <a href="https://identifiers.org/MESH:D003865">MESH:D003865 </a> | Major depressive disorder | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Vortioxetine | DECREASES ACTIVITY OF | Sodium-Dependent Serotonin Transporter |
| Sodium-Dependent Serotonin Transporter | POSITIVELY REGULATES | Serotonin Uptake |
| Serotonin Uptake | DECREASES ABUNDANCE OF | Serotonin |
| Serotonin | POSITIVELY CORRELATED WITH | Serotonin Secretion, Neurotransmission |
| Vortioxetine | INCREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 1A |
| Vortioxetine | DECREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 3A |
| Vortioxetine | DECREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 7 |
| Vortioxetine | INCREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 1B |
| 5-Hydroxytryptamine Receptor 3A | MOLECULARLY INTERACTS WITH | Serotonin |
| 5-Hydroxytryptamine Receptor 1A | MOLECULARLY INTERACTS WITH | Serotonin |
| 5-Hydroxytryptamine Receptor 7 | MOLECULARLY INTERACTS WITH | Serotonin |
| 5-Hydroxytryptamine Receptor 1B | MOLECULARLY INTERACTS WITH | Serotonin |
| Serotonin Secretion, Neurotransmission | NEGATIVELY CORRELATED WITH | Major Depressive Disorder |
|---------|-----------|---------|

Comment: Vortioxetine is classified as a serotonin modulator. How it works is not entirely clear but is believed to be related to increasing serotonin levels.

Reference: 
  - [https://go.drugbank.com/drugs/DB09068](https://go.drugbank.com/drugs/DB09068)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104993/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104993/)
